1. Home
  2. NSPR vs CURR Comparison

NSPR vs CURR Comparison

Compare NSPR & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • CURR
  • Stock Information
  • Founded
  • NSPR 2005
  • CURR 2013
  • Country
  • NSPR United States
  • CURR Singapore
  • Employees
  • NSPR N/A
  • CURR N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • CURR Business Services
  • Sector
  • NSPR Health Care
  • CURR Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • CURR Nasdaq
  • Market Cap
  • NSPR 75.1M
  • CURR 74.0M
  • IPO Year
  • NSPR N/A
  • CURR N/A
  • Fundamental
  • Price
  • NSPR $2.44
  • CURR $1.59
  • Analyst Decision
  • NSPR Strong Buy
  • CURR Strong Buy
  • Analyst Count
  • NSPR 2
  • CURR 1
  • Target Price
  • NSPR $4.50
  • CURR $3.50
  • AVG Volume (30 Days)
  • NSPR 386.2K
  • CURR 10.5M
  • Earning Date
  • NSPR 08-05-2025
  • CURR 08-11-2025
  • Dividend Yield
  • NSPR N/A
  • CURR N/A
  • EPS Growth
  • NSPR N/A
  • CURR N/A
  • EPS
  • NSPR N/A
  • CURR N/A
  • Revenue
  • NSPR $7,027,000.00
  • CURR $43,386,858.00
  • Revenue This Year
  • NSPR $4.85
  • CURR N/A
  • Revenue Next Year
  • NSPR $113.47
  • CURR $21.53
  • P/E Ratio
  • NSPR N/A
  • CURR N/A
  • Revenue Growth
  • NSPR 8.49
  • CURR N/A
  • 52 Week Low
  • NSPR $1.99
  • CURR $0.33
  • 52 Week High
  • NSPR $3.80
  • CURR $7.08
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 54.16
  • CURR N/A
  • Support Level
  • NSPR $2.12
  • CURR N/A
  • Resistance Level
  • NSPR $2.46
  • CURR N/A
  • Average True Range (ATR)
  • NSPR 0.16
  • CURR 0.00
  • MACD
  • NSPR 0.01
  • CURR 0.00
  • Stochastic Oscillator
  • NSPR 73.33
  • CURR 0.00

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.

Share on Social Networks: